Recurrence characteristics in European patients with ocular toxoplasmosis

The British Journal of Ophthalmology
J G GarwegM Halberstadt

Abstract

The risk of function loss after each episode of ocular toxoplasmosis (OT) supports efforts to improve our understanding of the disease. 139 patients with OT were contacted retrospectively and requested to complete a questionnaire addressing course and activity of their disease. This information was compared with that retrieved from their medical records. Sixty-three patients completed the questionnaire and were included in the study. They were allocated according to their median age to one of two groups (group 1: <20.9 years; group 2: >or=20.9 years). The mean reported age at the time of first ocular manifestation was 23.9 (median 20.9, range 0 to 70.5; SD 12.9) years. The clinical diagnosis was made 3.5 years later (p = 0.0008). The follow-up time was 6.5 (median 5.0; range 0.5 to 49.9; SD 7.6) years. The recurrence rate was higher in patients below 20.9 years (66%; n = 35) than in older patients (39%; n = 28; chi(2) test, p<0.05). Patients reporting only one episode were older at first manifestation (29.6 (median 25.6; range 10.6 to 70.5; SD 14.3) years; n = 29) than those reporting two episodes (17.9 (median 19.5; range 5.9 to 33.9; SD 7.8) years; n = 15 (p<0.05)). The proportion of patients who developed a recurrence was 54...Continue Reading

Citations

May 4, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sibylle WinterhalterAntonia Maria Joussen
Jan 10, 2012·Eye·B BodaghiP LeHoang
Mar 1, 2012·Eye·D Kovačević-PavićevićO Djurković-Djaković
Jan 15, 2014·Progress in Retinal and Eye Research·M MaenzU Pleyer
Sep 8, 2011·International Ophthalmology Clinics·Miriam Englander, Lucy H Y Young
Aug 1, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Guilherme Sturzeneker Cerqueira LimaFábio Petersen Saraiva
Jun 21, 2012·Clinical & Experimental Ophthalmology·Nicholas J ButlerJustine R Smith
Jun 22, 2014·Travel Medicine and Infectious Disease·Juan C Sepúlveda-AriasOlgica Djurković-Djaković
Apr 27, 2013·Ocular Immunology and Inflammation·Justus G Garweg, Miles R Stanford
Aug 26, 2011·Parasites & Vectors·Peng ZhouXing-Quan Zhu
Jul 15, 2015·The British Journal of Ophthalmology·Michael ReichFriederike Mackensen
Aug 16, 2016·American Journal of Ophthalmology·João Paulo Fernandes FelixCarlos Eduardo Leite Arieta
May 3, 2016·PLoS Neglected Tropical Diseases·Ana Luisa Quintella do Couto AleixoMaria Regina Reis Amendoeira
May 12, 2009·Memórias do Instituto Oswaldo Cruz·Gary N Holland
Jan 18, 2018·International Ophthalmology·Seyedeh Maryam HosseiniSeyed Aliakbar Shamsian
Mar 14, 2012·Ocular Immunology and Inflammation·Eskild PetersenMiles Stanford
Sep 15, 2015·Current Opinion in Ophthalmology·Michael Reich, Friederike Mackensen
Oct 30, 2020·Ophthalmic Epidemiology·Stefany Velasco-VelásquezJorge Enrique Gómez-Marín
Aug 20, 2019·Deutsches Ärzteblatt International·Uwe PleyerFrank Seeber
Apr 27, 2021·Heliyon·Jorge Enrique Gómez-MarínAlejandra de-la-Torre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

American Journal of Ophthalmology
E H Bosch-Driessen, A Rothova
Ophthalmology Clinics of North America
Anna Hovakimyan, Emmett T Cunningham
Archives of Ophthalmology
M J RondayA Rothova
© 2021 Meta ULC. All rights reserved